bromodeoxyuridine has been researched along with Conus Medullaris Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cizek, M; Cizkova, D; Hlucilova, J; Mechirova, E; Motlik, J; Nagyova, M; Novotna, I; Radonak, J; Slovinska, L; Sulla, I; Tomori, Z; Vanicky, I | 1 |
Kojima, A; Tator, CH | 1 |
2 other study(ies) available for bromodeoxyuridine and Conus Medullaris Syndrome
Article | Year |
---|---|
Response of ependymal progenitors to spinal cord injury or enhanced physical activity in adult rat.
Topics: Adult Stem Cells; Animals; Bromodeoxyuridine; Cell Count; Cell Proliferation; Ependyma; Immunohistochemistry; Male; Motor Activity; Rats; Rats, Wistar; Spinal Canal; Spinal Cord Compression; Spinal Cord Injuries; Thoracic Vertebrae | 2009 |
Intrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats.
Topics: Age Factors; Animals; Antigens; Antimetabolites; Biomarkers; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Lineage; Ependyma; Epidermal Growth Factor; Female; Fibroblast Growth Factor 2; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Spinal; Intermediate Filament Proteins; Nerve Tissue Proteins; Nestin; Proteoglycans; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Compression; Spinal Cord Injuries | 2002 |